Trademark: 77860437
Word
PREVENTIV MEASURES
Status
Dead
Status Code
602
Status Date
Wednesday, September 29, 2010
Serial Number
77860437
Mark Type
4000
Filing Date
Thursday, October 29, 2009
Abandoned Date
Thursday, August 5, 2010

Trademark Owner History

Classifications
5 Labels sold as an integral component of pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, anti-infectives, anti-inflammatory agents, anticonvulsants, antiemetics, anxiolytics, blood modifiers, cardiovasculars, diuretics, hormones, diluents, oncolytics, transplantation agents, imaging agents, vascular targeting agents, cancer treatments, and vascular disease treatments; Labels sold as an integral component of pre-filled syringes sold filled with alkalizing agents, labels sold as an integral component of pre-filled syringes sold filled with analgesics and anesthetics, labels sold as an integral component of pre-filled syringes sold filled with antacids, labels sold as an integral component of pre-filled syringes sold filled with anticholinergics, labels sold as an integral component of pre-filled syringes sold filled with anti-infectives, labels sold as an integral component of pre-filled syringes sold filled with anti-inflammatory agents, labels sold as an integral component of pre-filled syringes sold filled with anticonvulsants, labels sold as an integral component of pre-filled syringes sold filled with antiemetics, labels sold as an integral component of pre-filled syringes sold filled with anxiolytics, labels sold as an integral component of pre-filled syringes sold filled with blood modifiers, labels sold as an integral component of pre-filled syringes sold filled with cardiovasculars, labels sold as an integral component of pre-filled syringes sold filled with diuretics, labels sold as an integral component of pre-filled syringes sold filled with hormones, labels sold as an integral component of pre-filled syringes sold filled with diluents, labels sold as an integral component of pre-filled syringes sold filled with oncolytics, labels sold as an integral component of pre-filled syringes sold filled with transplantation agents, labels sold as an integral component of pre-filled syringes sold filled with imaging agents, labels sold as an integral component of pre-filled syringes sold filled with vascular targeting agents, labels sold as an integral component of pre-filled syringes sold filled with cancer treatments, and labels sold as an integral component of pre-filled syringes sold filled with vascular disease treatments; Labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of pain; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of infections; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of heartburn; labels sold as an integral component of injectable drugs and therapeutic solutions for imaging; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors
PREVENTIVE MEASURES

Trademark Events
Sep 29, 2010
Abandonment Notice Mailed - Failure To Respond
Sep 29, 2010
Abandonment - Failure To Respond Or Late Response
Feb 4, 2010
Notification Of Non-Final Action E-Mailed
Feb 4, 2010
Non-Final Action E-Mailed
Feb 4, 2010
Non-Final Action Written
Feb 3, 2010
Assigned To Examiner
Nov 5, 2009
Notice Of Pseudo Mark Mailed
Nov 4, 2009
New Application Office Supplied Data Entered In Tram
Nov 2, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24